

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | central nervous system myelination (GO:0022010) | 6.24256275 |
| 2 | axon ensheathment in central nervous system (GO:0032291) | 6.24256275 |
| 3 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.23641440 |
| 4 | synaptic vesicle maturation (GO:0016188) | 4.85776817 |
| 5 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.63656895 |
| 6 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.49638133 |
| 7 | synaptic vesicle exocytosis (GO:0016079) | 4.35985432 |
| 8 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.24185902 |
| 9 | locomotory exploration behavior (GO:0035641) | 4.21556085 |
| 10 | glutamate secretion (GO:0014047) | 4.21303000 |
| 11 | amino acid import (GO:0043090) | 4.20519644 |
| 12 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.17214838 |
| 13 | cerebellar granule cell differentiation (GO:0021707) | 4.08559114 |
| 14 | neuronal ion channel clustering (GO:0045161) | 4.06354250 |
| 15 | positive regulation of synapse maturation (GO:0090129) | 4.02898926 |
| 16 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.97121366 |
| 17 | vocalization behavior (GO:0071625) | 3.96241910 |
| 18 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.86124505 |
| 19 | cellular potassium ion homeostasis (GO:0030007) | 3.78622464 |
| 20 | regulation of synapse structural plasticity (GO:0051823) | 3.75810226 |
| 21 | regulation of synaptic vesicle transport (GO:1902803) | 3.65932495 |
| 22 | synaptic vesicle endocytosis (GO:0048488) | 3.64986785 |
| 23 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.63862372 |
| 24 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.63585142 |
| 25 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.61256739 |
| 26 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.57984911 |
| 27 | cell communication involved in cardiac conduction (GO:0086065) | 3.55887123 |
| 28 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.52839400 |
| 29 | protein localization to synapse (GO:0035418) | 3.52514761 |
| 30 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.48887517 |
| 31 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.47852423 |
| 32 | regulation of synapse maturation (GO:0090128) | 3.47267257 |
| 33 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.43905268 |
| 34 | glutamate receptor signaling pathway (GO:0007215) | 3.41975122 |
| 35 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.38451212 |
| 36 | sodium ion export (GO:0071436) | 3.36000834 |
| 37 | presynaptic membrane organization (GO:0097090) | 3.34572143 |
| 38 | synaptic transmission, glutamatergic (GO:0035249) | 3.31238122 |
| 39 | myelin maintenance (GO:0043217) | 3.30812452 |
| 40 | positive regulation of dendritic spine development (GO:0060999) | 3.26299758 |
| 41 | exploration behavior (GO:0035640) | 3.26030836 |
| 42 | presynaptic membrane assembly (GO:0097105) | 3.25413230 |
| 43 | regulation of ARF protein signal transduction (GO:0032012) | 3.25085831 |
| 44 | layer formation in cerebral cortex (GO:0021819) | 3.24154803 |
| 45 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.24111365 |
| 46 | neuron-neuron synaptic transmission (GO:0007270) | 3.23802340 |
| 47 | neuron cell-cell adhesion (GO:0007158) | 3.23000749 |
| 48 | regulation of clathrin-mediated endocytosis (GO:2000369) | 3.21795285 |
| 49 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.20371305 |
| 50 | innervation (GO:0060384) | 3.18577662 |
| 51 | postsynaptic membrane organization (GO:0001941) | 3.16214555 |
| 52 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.14954543 |
| 53 | proline transport (GO:0015824) | 3.13652935 |
| 54 | long-chain fatty acid biosynthetic process (GO:0042759) | 3.13539434 |
| 55 | neuron recognition (GO:0008038) | 3.13243653 |
| 56 | regulation of neurotransmitter levels (GO:0001505) | 3.11312526 |
| 57 | dendrite morphogenesis (GO:0048813) | 3.11144276 |
| 58 | regulation of postsynaptic membrane potential (GO:0060078) | 3.08990356 |
| 59 | long-term synaptic potentiation (GO:0060291) | 3.08250538 |
| 60 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.07988157 |
| 61 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.05877431 |
| 62 | myelination (GO:0042552) | 3.05488731 |
| 63 | neurotransmitter secretion (GO:0007269) | 3.05017407 |
| 64 | auditory behavior (GO:0031223) | 3.04606033 |
| 65 | neurotransmitter uptake (GO:0001504) | 3.04468444 |
| 66 | mating behavior (GO:0007617) | 3.02533991 |
| 67 | gamma-aminobutyric acid transport (GO:0015812) | 3.02068037 |
| 68 | long-term memory (GO:0007616) | 3.01328009 |
| 69 | detection of calcium ion (GO:0005513) | 2.99597105 |
| 70 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.99025370 |
| 71 | axon ensheathment (GO:0008366) | 2.98221857 |
| 72 | ensheathment of neurons (GO:0007272) | 2.98221857 |
| 73 | regulation of synaptic plasticity (GO:0048167) | 2.97818001 |
| 74 | long term synaptic depression (GO:0060292) | 2.97578331 |
| 75 | dendritic spine morphogenesis (GO:0060997) | 2.97197532 |
| 76 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.96463773 |
| 77 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.95596302 |
| 78 | negative regulation of inclusion body assembly (GO:0090084) | 2.94366449 |
| 79 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.94195357 |
| 80 | behavioral defense response (GO:0002209) | 2.94009156 |
| 81 | behavioral fear response (GO:0001662) | 2.94009156 |
| 82 | axonal fasciculation (GO:0007413) | 2.93003337 |
| 83 | L-amino acid import (GO:0043092) | 2.91120305 |
| 84 | acidic amino acid transport (GO:0015800) | 2.89152291 |
| 85 | nerve growth factor signaling pathway (GO:0038180) | 2.89071390 |
| 86 | response to histamine (GO:0034776) | 2.88974281 |
| 87 | astrocyte development (GO:0014002) | 2.87896179 |
| 88 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.86814336 |
| 89 | vesicle transport along microtubule (GO:0047496) | 2.84670737 |
| 90 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 2.82260002 |
| 91 | negative regulation of hormone biosynthetic process (GO:0032353) | 2.81028670 |
| 92 | negative regulation of hormone metabolic process (GO:0032351) | 2.81028670 |
| 93 | membrane depolarization during action potential (GO:0086010) | 2.79943044 |
| 94 | positive regulation of membrane potential (GO:0045838) | 2.79419329 |
| 95 | neuronal action potential propagation (GO:0019227) | 2.79091218 |
| 96 | membrane hyperpolarization (GO:0060081) | 2.78500602 |
| 97 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.78370281 |
| 98 | prepulse inhibition (GO:0060134) | 2.77738340 |
| 99 | cell migration in hindbrain (GO:0021535) | 2.77412616 |
| 100 | regulation of neurotransmitter secretion (GO:0046928) | 2.75765231 |
| 101 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 2.75557137 |
| 102 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 2.75557137 |
| 103 | chemosensory behavior (GO:0007635) | 2.75538297 |
| 104 | fear response (GO:0042596) | 2.75391826 |
| 105 | membrane assembly (GO:0071709) | 2.74608557 |
| 106 | sodium ion homeostasis (GO:0055078) | 2.74008332 |
| 107 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.73222708 |
| 108 | potassium ion import (GO:0010107) | 2.73054904 |
| 109 | membrane depolarization (GO:0051899) | 2.72827892 |
| 110 | cell communication by electrical coupling (GO:0010644) | 2.72113619 |
| 111 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.71265053 |
| 112 | regulation of neurotransmitter transport (GO:0051588) | 2.69808871 |
| 113 | positive regulation of dendrite development (GO:1900006) | 2.68342938 |
| 114 | striatum development (GO:0021756) | 2.67672843 |
| 115 | neuromuscular process controlling balance (GO:0050885) | 2.67498067 |
| 116 | cell differentiation in hindbrain (GO:0021533) | 2.67114296 |
| 117 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.65435991 |
| 118 | serotonin metabolic process (GO:0042428) | 2.65335400 |
| 119 | regulation of dendritic spine development (GO:0060998) | 2.65009820 |
| 120 | positive regulation of potassium ion transport (GO:0043268) | 2.64972919 |
| 121 | regulation of neurotransmitter uptake (GO:0051580) | 2.64239472 |
| 122 | regulation of sodium ion transmembrane transporter activity (GO:2000649) | 2.64050473 |
| 123 | potassium ion homeostasis (GO:0055075) | 2.63397450 |
| 124 | behavioral response to cocaine (GO:0048148) | 2.62903609 |
| 125 | regulation of vesicle fusion (GO:0031338) | 2.61552861 |
| 126 | cellular sodium ion homeostasis (GO:0006883) | 2.61246620 |
| 127 | response to auditory stimulus (GO:0010996) | 2.61035465 |
| 128 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.60803336 |
| 129 | positive regulation of neurotransmitter transport (GO:0051590) | 2.60276954 |
| 130 | neurotransmitter transport (GO:0006836) | 2.59294354 |
| 131 | * regulation of Rap GTPase activity (GO:0032317) | 2.58936979 |
| 132 | positive regulation of sodium ion transmembrane transporter activity (GO:2000651) | 2.58742374 |
| 133 | clathrin coat assembly (GO:0048268) | 2.58336806 |
| 134 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.56738107 |
| 135 | transmission of nerve impulse (GO:0019226) | 2.56316366 |
| 136 | activation of protein kinase A activity (GO:0034199) | 2.56187447 |
| 137 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.55536903 |
| 138 | neuromuscular process controlling posture (GO:0050884) | 2.53045374 |
| 139 | organelle transport along microtubule (GO:0072384) | 2.51622408 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.62967590 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.60039813 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.45499584 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.44712074 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.29557034 |
| 6 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.15098802 |
| 7 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.14594533 |
| 8 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.14594533 |
| 9 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.13269359 |
| 10 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.12052364 |
| 11 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.09917293 |
| 12 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.08349683 |
| 13 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.02562910 |
| 14 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.99885070 |
| 15 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.99308851 |
| 16 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.97164532 |
| 17 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.96801299 |
| 18 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.92605356 |
| 19 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.87482804 |
| 20 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.85864633 |
| 21 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.85605571 |
| 22 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.82140146 |
| 23 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.76947166 |
| 24 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.76573776 |
| 25 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.76053863 |
| 26 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.74537233 |
| 27 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.70806370 |
| 28 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.63587608 |
| 29 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.61678645 |
| 30 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.60062082 |
| 31 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.57577227 |
| 32 | * CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.54630552 |
| 33 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.51345211 |
| 34 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.50191793 |
| 35 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.49458117 |
| 36 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.49092409 |
| 37 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.47536017 |
| 38 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.45914002 |
| 39 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.45545741 |
| 40 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.44216221 |
| 41 | STAT3_23295773_ChIP-Seq_U87_Human | 1.44115486 |
| 42 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.43422407 |
| 43 | P300_19829295_ChIP-Seq_ESCs_Human | 1.42002980 |
| 44 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.38741844 |
| 45 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.38522361 |
| 46 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.37875004 |
| 47 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.37487213 |
| 48 | AR_25329375_ChIP-Seq_VCAP_Human | 1.37033177 |
| 49 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.36437111 |
| 50 | * SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.36170836 |
| 51 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.34821845 |
| 52 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.33912234 |
| 53 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.33546939 |
| 54 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.33465351 |
| 55 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.33373493 |
| 56 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.33289850 |
| 57 | * NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.33194644 |
| 58 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.32875348 |
| 59 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.31206260 |
| 60 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.30238527 |
| 61 | TP53_16413492_ChIP-PET_HCT116_Human | 1.29259132 |
| 62 | * EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.26615299 |
| 63 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.25409669 |
| 64 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.24646640 |
| 65 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.24305829 |
| 66 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.22581866 |
| 67 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.22129347 |
| 68 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.20981958 |
| 69 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.20919424 |
| 70 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.20191606 |
| 71 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.16775998 |
| 72 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.16724176 |
| 73 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.14366517 |
| 74 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.13479306 |
| 75 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.13182431 |
| 76 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.13031295 |
| 77 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.12910952 |
| 78 | AR_19668381_ChIP-Seq_PC3_Human | 1.12787143 |
| 79 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.11887431 |
| 80 | FUS_26573619_Chip-Seq_HEK293_Human | 1.11788616 |
| 81 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.11022139 |
| 82 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.10653500 |
| 83 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.10035566 |
| 84 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.09749615 |
| 85 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.09405162 |
| 86 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.07760360 |
| 87 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.07607026 |
| 88 | * RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.07461231 |
| 89 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.06563175 |
| 90 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.06202647 |
| 91 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.05554971 |
| 92 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.05349864 |
| 93 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.04931478 |
| 94 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.03897300 |
| 95 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.02512347 |
| 96 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.02512347 |
| 97 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.01974755 |
| 98 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.01901290 |
| 99 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.01570863 |
| 100 | KDM2B_26808549_Chip-Seq_K562_Human | 1.00435368 |
| 101 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.00286889 |
| 102 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.00222070 |
| 103 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.98607216 |
| 104 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.98173162 |
| 105 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.97912237 |
| 106 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 0.97423158 |
| 107 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.97074220 |
| 108 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.95464747 |
| 109 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 0.95290283 |
| 110 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95185176 |
| 111 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.94515060 |
| 112 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.94082608 |
| 113 | * STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.94039942 |
| 114 | RXR_22108803_ChIP-Seq_LS180_Human | 0.93727177 |
| 115 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.93691522 |
| 116 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.93415789 |
| 117 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.93092346 |
| 118 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.89492902 |
| 119 | * DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.88833273 |
| 120 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.87717060 |
| 121 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.86661498 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.38693361 |
| 2 | MP0003880_abnormal_central_pattern | 4.71725788 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 3.64387523 |
| 4 | MP0004270_analgesia | 3.50193951 |
| 5 | MP0002063_abnormal_learning/memory/cond | 3.02557398 |
| 6 | MP0009745_abnormal_behavioral_response | 2.77309791 |
| 7 | MP0002064_seizures | 2.67205260 |
| 8 | MP0002822_catalepsy | 2.56421181 |
| 9 | MP0001968_abnormal_touch/_nociception | 2.39261556 |
| 10 | MP0002572_abnormal_emotion/affect_behav | 2.37144002 |
| 11 | MP0001486_abnormal_startle_reflex | 2.29968277 |
| 12 | MP0005423_abnormal_somatic_nervous | 2.29060489 |
| 13 | MP0000569_abnormal_digit_pigmentation | 2.27793893 |
| 14 | MP0002734_abnormal_mechanical_nocicepti | 2.19515784 |
| 15 | MP0005551_abnormal_eye_electrophysiolog | 2.18940495 |
| 16 | MP0005167_abnormal_blood-brain_barrier | 2.16553568 |
| 17 | MP0010368_abnormal_lymphatic_system | 2.08235767 |
| 18 | MP0002272_abnormal_nervous_system | 2.07295626 |
| 19 | MP0009046_muscle_twitch | 1.94407565 |
| 20 | MP0001501_abnormal_sleep_pattern | 1.88564172 |
| 21 | MP0002736_abnormal_nociception_after | 1.88042972 |
| 22 | MP0000778_abnormal_nervous_system | 1.87731010 |
| 23 | MP0003329_amyloid_beta_deposits | 1.86103038 |
| 24 | MP0001440_abnormal_grooming_behavior | 1.82123054 |
| 25 | MP0009780_abnormal_chondrocyte_physiolo | 1.72959705 |
| 26 | MP0001905_abnormal_dopamine_level | 1.70525460 |
| 27 | MP0005386_behavior/neurological_phenoty | 1.64460738 |
| 28 | MP0004924_abnormal_behavior | 1.64460738 |
| 29 | MP0003787_abnormal_imprinting | 1.63682092 |
| 30 | MP0002067_abnormal_sensory_capabilities | 1.62866213 |
| 31 | MP0001970_abnormal_pain_threshold | 1.52125837 |
| 32 | MP0002735_abnormal_chemical_nociception | 1.50975529 |
| 33 | MP0010234_abnormal_vibrissa_follicle | 1.50305797 |
| 34 | MP0003633_abnormal_nervous_system | 1.46933998 |
| 35 | MP0004215_abnormal_myocardial_fiber | 1.46837387 |
| 36 | MP0002733_abnormal_thermal_nociception | 1.46672416 |
| 37 | MP0004811_abnormal_neuron_physiology | 1.46451384 |
| 38 | MP0001502_abnormal_circadian_rhythm | 1.46328908 |
| 39 | MP0001529_abnormal_vocalization | 1.44688493 |
| 40 | MP0002184_abnormal_innervation | 1.37120851 |
| 41 | MP0004484_altered_response_of | 1.36909021 |
| 42 | MP0003646_muscle_fatigue | 1.36185509 |
| 43 | MP0002882_abnormal_neuron_morphology | 1.35829693 |
| 44 | MP0005409_darkened_coat_color | 1.35075657 |
| 45 | MP0002090_abnormal_vision | 1.32963374 |
| 46 | MP0003631_nervous_system_phenotype | 1.31267460 |
| 47 | MP0003075_altered_response_to | 1.30015037 |
| 48 | MP0005646_abnormal_pituitary_gland | 1.29331386 |
| 49 | MP0000678_abnormal_parathyroid_gland | 1.29035928 |
| 50 | MP0008569_lethality_at_weaning | 1.28671279 |
| 51 | MP0002557_abnormal_social/conspecific_i | 1.28579046 |
| 52 | MP0006072_abnormal_retinal_apoptosis | 1.26526922 |
| 53 | MP0002229_neurodegeneration | 1.24601540 |
| 54 | MP0006276_abnormal_autonomic_nervous | 1.21865747 |
| 55 | MP0004742_abnormal_vestibular_system | 1.21085052 |
| 56 | MP0004510_myositis | 1.19756350 |
| 57 | MP0004885_abnormal_endolymph | 1.19719773 |
| 58 | MP0004858_abnormal_nervous_system | 1.19685785 |
| 59 | MP0003690_abnormal_glial_cell | 1.19360073 |
| 60 | MP0004085_abnormal_heartbeat | 1.19077391 |
| 61 | MP0000566_synostosis | 1.19061463 |
| 62 | MP0003879_abnormal_hair_cell | 1.18902512 |
| 63 | MP0001879_abnormal_lymphatic_vessel | 1.18271708 |
| 64 | MP0000751_myopathy | 1.17774344 |
| 65 | MP0005187_abnormal_penis_morphology | 1.17446432 |
| 66 | MP0003950_abnormal_plasma_membrane | 1.17189033 |
| 67 | MP0010386_abnormal_urinary_bladder | 1.16771146 |
| 68 | MP0003122_maternal_imprinting | 1.15091121 |
| 69 | MP0000955_abnormal_spinal_cord | 1.13042993 |
| 70 | MP0002066_abnormal_motor_capabilities/c | 1.12828121 |
| 71 | MP0002909_abnormal_adrenal_gland | 1.08709455 |
| 72 | MP0002332_abnormal_exercise_endurance | 1.08554092 |
| 73 | MP0000604_amyloidosis | 1.07799907 |
| 74 | MP0003123_paternal_imprinting | 1.06050310 |
| 75 | MP0004036_abnormal_muscle_relaxation | 1.03490912 |
| 76 | MP0004147_increased_porphyrin_level | 1.03288985 |
| 77 | MP0003632_abnormal_nervous_system | 1.03267558 |
| 78 | MP0005253_abnormal_eye_physiology | 1.02392057 |
| 79 | MP0001299_abnormal_eye_distance/ | 1.01237033 |
| 80 | MP0002152_abnormal_brain_morphology | 0.99859081 |
| 81 | MP0005595_abnormal_vascular_smooth | 0.99660155 |
| 82 | MP0005195_abnormal_posterior_eye | 0.97544633 |
| 83 | MP0004084_abnormal_cardiac_muscle | 0.97136236 |
| 84 | MP0008874_decreased_physiological_sensi | 0.96574075 |
| 85 | MP0002638_abnormal_pupillary_reflex | 0.95778446 |
| 86 | MP0001485_abnormal_pinna_reflex | 0.95498137 |
| 87 | MP0004233_abnormal_muscle_weight | 0.91969355 |
| 88 | MP0001346_abnormal_lacrimal_gland | 0.88704284 |
| 89 | MP0001851_eye_inflammation | 0.88533798 |
| 90 | MP0004145_abnormal_muscle_electrophysio | 0.88009567 |
| 91 | MP0001963_abnormal_hearing_physiology | 0.87375412 |
| 92 | MP0002102_abnormal_ear_morphology | 0.84415308 |
| 93 | MP0001177_atelectasis | 0.83736236 |
| 94 | MP0003868_abnormal_feces_composition | 0.83582898 |
| 95 | MP0002752_abnormal_somatic_nervous | 0.83204882 |
| 96 | MP0003303_peritoneal_inflammation | 0.81580157 |
| 97 | MP0005645_abnormal_hypothalamus_physiol | 0.81355047 |
| 98 | MP0003634_abnormal_glial_cell | 0.81297757 |
| 99 | MP0002653_abnormal_ependyma_morphology | 0.79822760 |
| 100 | MP0001984_abnormal_olfaction | 0.77934333 |
| 101 | MP0000920_abnormal_myelination | 0.77217493 |
| 102 | MP0003045_fibrosis | 0.76759624 |
| 103 | MP0004782_abnormal_surfactant_physiolog | 0.75310031 |
| 104 | MP0005620_abnormal_muscle_contractility | 0.73180788 |
| 105 | MP0004130_abnormal_muscle_cell | 0.72000561 |
| 106 | MP0005394_taste/olfaction_phenotype | 0.71491628 |
| 107 | MP0005499_abnormal_olfactory_system | 0.71491628 |
| 108 | MP0002837_dystrophic_cardiac_calcinosis | 0.70386649 |
| 109 | MP0003172_abnormal_lysosome_physiology | 0.68626826 |
| 110 | MP0006138_congestive_heart_failure | 0.67181212 |
| 111 | MP0004883_abnormal_blood_vessel | 0.62945558 |
| 112 | MP0008872_abnormal_physiological_respon | 0.62489108 |
| 113 | MP0004185_abnormal_adipocyte_glucose | 0.62311825 |
| 114 | MP0010769_abnormal_survival | 0.62272172 |
| 115 | MP0002082_postnatal_lethality | 0.60092353 |
| 116 | MP0010770_preweaning_lethality | 0.60092353 |
| 117 | MP0002069_abnormal_eating/drinking_beha | 0.59704642 |
| 118 | MP0002133_abnormal_respiratory_system | 0.59607325 |
| 119 | MP0005388_respiratory_system_phenotype | 0.59607325 |
| 120 | MP0005535_abnormal_body_temperature | 0.57895997 |
| 121 | MP0010768_mortality/aging | 0.57582251 |
| 122 | MP0001943_abnormal_respiration | 0.57550250 |
| 123 | MP0001986_abnormal_taste_sensitivity | 0.57022019 |
| 124 | MP0000747_muscle_weakness | 0.55094695 |
| 125 | MP0000579_abnormal_nail_morphology | 0.54607974 |
| 126 | MP0005623_abnormal_meninges_morphology | 0.50808863 |
| 127 | MP0005670_abnormal_white_adipose | 0.50324291 |
| 128 | MP0003137_abnormal_impulse_conducting | 0.47817765 |
| 129 | MP0001765_abnormal_ion_homeostasis | 0.47434948 |
| 130 | MP0003861_abnormal_nervous_system | 0.47427835 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 5.67591916 |
| 2 | Myokymia (HP:0002411) | 5.40121761 |
| 3 | Focal seizures (HP:0007359) | 4.31700873 |
| 4 | Congenital stationary night blindness (HP:0007642) | 3.99874318 |
| 5 | Epileptic encephalopathy (HP:0200134) | 3.81741035 |
| 6 | Mutism (HP:0002300) | 3.75965449 |
| 7 | Supranuclear gaze palsy (HP:0000605) | 3.68863096 |
| 8 | Alacrima (HP:0000522) | 3.58870062 |
| 9 | Arterial tortuosity (HP:0005116) | 3.56789464 |
| 10 | Central scotoma (HP:0000603) | 3.52222457 |
| 11 | Neurofibrillary tangles (HP:0002185) | 3.47693023 |
| 12 | Abnormality of macular pigmentation (HP:0008002) | 3.40103765 |
| 13 | Febrile seizures (HP:0002373) | 3.39105903 |
| 14 | Visual hallucinations (HP:0002367) | 3.35130266 |
| 15 | Vascular tortuosity (HP:0004948) | 3.34231595 |
| 16 | Atonic seizures (HP:0010819) | 3.30903653 |
| 17 | Progressive cerebellar ataxia (HP:0002073) | 3.27178375 |
| 18 | Cerebral inclusion bodies (HP:0100314) | 3.22907137 |
| 19 | Action tremor (HP:0002345) | 3.21475727 |
| 20 | Absence seizures (HP:0002121) | 3.09904284 |
| 21 | Dysmetria (HP:0001310) | 2.98715827 |
| 22 | Insidious onset (HP:0003587) | 2.97321687 |
| 23 | Termporal pattern (HP:0011008) | 2.97321687 |
| 24 | Generalized tonic-clonic seizures (HP:0002069) | 2.96812828 |
| 25 | Dialeptic seizures (HP:0011146) | 2.96323588 |
| 26 | Increased circulating renin level (HP:0000848) | 2.96134688 |
| 27 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.93852023 |
| 28 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.92996964 |
| 29 | Excessive salivation (HP:0003781) | 2.82701318 |
| 30 | Drooling (HP:0002307) | 2.82701318 |
| 31 | Decreased lacrimation (HP:0000633) | 2.79058067 |
| 32 | Postural instability (HP:0002172) | 2.78632500 |
| 33 | Obstructive sleep apnea (HP:0002870) | 2.77124644 |
| 34 | Ankle clonus (HP:0011448) | 2.76325604 |
| 35 | Abnormality of the corticospinal tract (HP:0002492) | 2.69957225 |
| 36 | Amblyopia (HP:0000646) | 2.64651315 |
| 37 | Hemiparesis (HP:0001269) | 2.63975429 |
| 38 | Abnormal eating behavior (HP:0100738) | 2.59257825 |
| 39 | Scotoma (HP:0000575) | 2.58043697 |
| 40 | Limb dystonia (HP:0002451) | 2.56597792 |
| 41 | Broad-based gait (HP:0002136) | 2.53899601 |
| 42 | Dysdiadochokinesis (HP:0002075) | 2.49708943 |
| 43 | Aplasia involving bones of the extremities (HP:0009825) | 2.49199260 |
| 44 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.49199260 |
| 45 | Aplasia of the phalanges of the hand (HP:0009802) | 2.49199260 |
| 46 | Abnormality of the lower motor neuron (HP:0002366) | 2.47022730 |
| 47 | Akinesia (HP:0002304) | 2.43428888 |
| 48 | Depression (HP:0000716) | 2.43053213 |
| 49 | Neuronal loss in central nervous system (HP:0002529) | 2.42415049 |
| 50 | Hyperphosphatemia (HP:0002905) | 2.42010217 |
| 51 | Spastic gait (HP:0002064) | 2.41867281 |
| 52 | Status epilepticus (HP:0002133) | 2.41754920 |
| 53 | Genetic anticipation (HP:0003743) | 2.40371198 |
| 54 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.39397487 |
| 55 | Truncal ataxia (HP:0002078) | 2.39052419 |
| 56 | Annular pancreas (HP:0001734) | 2.37376215 |
| 57 | Urinary urgency (HP:0000012) | 2.35694300 |
| 58 | Syncope (HP:0001279) | 2.33320777 |
| 59 | Poor eye contact (HP:0000817) | 2.32899099 |
| 60 | Bronchomalacia (HP:0002780) | 2.32615465 |
| 61 | Bundle branch block (HP:0011710) | 2.32407176 |
| 62 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.32294359 |
| 63 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.32294359 |
| 64 | Ventricular fibrillation (HP:0001663) | 2.31852178 |
| 65 | Papilledema (HP:0001085) | 2.29234253 |
| 66 | Hemiplegia (HP:0002301) | 2.28802371 |
| 67 | Rapidly progressive (HP:0003678) | 2.26804649 |
| 68 | Clonus (HP:0002169) | 2.26318188 |
| 69 | Lower limb muscle weakness (HP:0007340) | 2.26181100 |
| 70 | Gaze-evoked nystagmus (HP:0000640) | 2.25461223 |
| 71 | Cerebral hypomyelination (HP:0006808) | 2.25003479 |
| 72 | Intention tremor (HP:0002080) | 2.23849195 |
| 73 | Scanning speech (HP:0002168) | 2.19170821 |
| 74 | Polyphagia (HP:0002591) | 2.19068034 |
| 75 | Peripheral hypomyelination (HP:0007182) | 2.18967203 |
| 76 | Incomplete penetrance (HP:0003829) | 2.14258873 |
| 77 | Onion bulb formation (HP:0003383) | 2.14000766 |
| 78 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.13324349 |
| 79 | Absent speech (HP:0001344) | 2.11350887 |
| 80 | Spastic tetraparesis (HP:0001285) | 2.11337414 |
| 81 | Apathy (HP:0000741) | 2.11110949 |
| 82 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.09609379 |
| 83 | Decreased number of peripheral myelinated nerve fibers (HP:0003380) | 2.09275395 |
| 84 | Tetraplegia (HP:0002445) | 2.07663866 |
| 85 | Inappropriate behavior (HP:0000719) | 2.07387761 |
| 86 | Abnormal social behavior (HP:0012433) | 2.07129140 |
| 87 | Impaired social interactions (HP:0000735) | 2.07129140 |
| 88 | Megalencephaly (HP:0001355) | 2.06903772 |
| 89 | Diplopia (HP:0000651) | 2.04638206 |
| 90 | Abnormality of binocular vision (HP:0011514) | 2.04638206 |
| 91 | Abnormality of salivation (HP:0100755) | 2.04505028 |
| 92 | Exotropia (HP:0000577) | 2.02763745 |
| 93 | Anxiety (HP:0000739) | 2.00315840 |
| 94 | Anterior segment dysgenesis (HP:0007700) | 1.99799416 |
| 95 | Decreased motor nerve conduction velocity (HP:0003431) | 1.99080606 |
| 96 | Urethral obstruction (HP:0000796) | 1.98413929 |
| 97 | Torticollis (HP:0000473) | 1.98292088 |
| 98 | Abnormality of the periventricular white matter (HP:0002518) | 1.97409728 |
| 99 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.97026446 |
| 100 | Sleep apnea (HP:0010535) | 1.96905447 |
| 101 | Stereotypic behavior (HP:0000733) | 1.93487091 |
| 102 | Generalized myoclonic seizures (HP:0002123) | 1.93131559 |
| 103 | Insomnia (HP:0100785) | 1.91904902 |
| 104 | Impaired vibratory sensation (HP:0002495) | 1.91067743 |
| 105 | Choroideremia (HP:0001139) | 1.90626856 |
| 106 | Rigidity (HP:0002063) | 1.90275495 |
| 107 | Cerebral hemorrhage (HP:0001342) | 1.90205085 |
| 108 | Focal dystonia (HP:0004373) | 1.89449863 |
| 109 | Pheochromocytoma (HP:0002666) | 1.87914673 |
| 110 | Primary atrial arrhythmia (HP:0001692) | 1.87894737 |
| 111 | Choreoathetosis (HP:0001266) | 1.87086129 |
| 112 | Atrial fibrillation (HP:0005110) | 1.87049496 |
| 113 | Thickened helices (HP:0000391) | 1.86557738 |
| 114 | Heart block (HP:0012722) | 1.85404361 |
| 115 | Hyperventilation (HP:0002883) | 1.84251039 |
| 116 | Epileptiform EEG discharges (HP:0011182) | 1.84238347 |
| 117 | Hypsarrhythmia (HP:0002521) | 1.83958451 |
| 118 | Progressive inability to walk (HP:0002505) | 1.83584102 |
| 119 | Hematochezia (HP:0002573) | 1.83409031 |
| 120 | Prolonged QT interval (HP:0001657) | 1.82863357 |
| 121 | Craniofacial dystonia (HP:0012179) | 1.81640019 |
| 122 | Spastic paraplegia (HP:0001258) | 1.79863208 |
| 123 | Retinal atrophy (HP:0001105) | 1.77511295 |
| 124 | Bradykinesia (HP:0002067) | 1.76755863 |
| 125 | Diminished motivation (HP:0000745) | 1.76556394 |
| 126 | Hammertoe (HP:0001765) | 1.76484631 |
| 127 | Impaired smooth pursuit (HP:0007772) | 1.76004563 |
| 128 | Turricephaly (HP:0000262) | 1.75968974 |
| 129 | Hyporeflexia of lower limbs (HP:0002600) | 1.75660512 |
| 130 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.75077742 |
| 131 | Gait imbalance (HP:0002141) | 1.74814647 |
| 132 | Dysmetric saccades (HP:0000641) | 1.74566013 |
| 133 | Specific learning disability (HP:0001328) | 1.73877230 |
| 134 | Supraventricular arrhythmia (HP:0005115) | 1.73476755 |
| 135 | EEG with generalized epileptiform discharges (HP:0011198) | 1.71534171 |
| 136 | Pointed chin (HP:0000307) | 1.71288669 |
| 137 | Papillary thyroid carcinoma (HP:0002895) | 1.71143721 |
| 138 | Lower limb asymmetry (HP:0100559) | 1.70865214 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K9 | 5.02133642 |
| 2 | EPHA4 | 3.75901649 |
| 3 | NTRK3 | 3.36522540 |
| 4 | MAP3K4 | 3.23605096 |
| 5 | KSR2 | 3.04229087 |
| 6 | UHMK1 | 2.93219772 |
| 7 | TIE1 | 2.61178458 |
| 8 | PAK6 | 2.52676423 |
| 9 | MARK1 | 2.27029627 |
| 10 | DAPK2 | 2.04552004 |
| 11 | PRKD3 | 2.01908493 |
| 12 | MAP3K13 | 1.94521098 |
| 13 | MAP2K7 | 1.83793620 |
| 14 | MINK1 | 1.80410763 |
| 15 | MAP3K6 | 1.80070130 |
| 16 | NTRK2 | 1.72730232 |
| 17 | MAP2K4 | 1.70896944 |
| 18 | KSR1 | 1.65873859 |
| 19 | RIPK4 | 1.64734280 |
| 20 | LATS2 | 1.55671907 |
| 21 | STK38 | 1.49473390 |
| 22 | PTK2B | 1.44502645 |
| 23 | TGFBR2 | 1.36812777 |
| 24 | NTRK1 | 1.35974447 |
| 25 | ARAF | 1.30858577 |
| 26 | FES | 1.28377661 |
| 27 | MAPK13 | 1.27302345 |
| 28 | PLK2 | 1.26496253 |
| 29 | CDK5 | 1.26010981 |
| 30 | RAF1 | 1.21404382 |
| 31 | TYRO3 | 1.21339446 |
| 32 | SGK223 | 1.18213655 |
| 33 | SGK494 | 1.18213655 |
| 34 | CAMK1G | 1.18097205 |
| 35 | DMPK | 1.15220699 |
| 36 | RET | 1.11950317 |
| 37 | WNK1 | 1.07066412 |
| 38 | TAOK1 | 1.04803039 |
| 39 | NEK6 | 1.04201592 |
| 40 | FGFR2 | 1.03859231 |
| 41 | MAPKAPK5 | 1.03780082 |
| 42 | MARK2 | 1.03149789 |
| 43 | GRK5 | 1.02569610 |
| 44 | CAMKK1 | 1.00695266 |
| 45 | FER | 0.99757625 |
| 46 | FGR | 0.97726791 |
| 47 | CAMK2A | 0.96041895 |
| 48 | BMPR2 | 0.95882282 |
| 49 | MAP3K2 | 0.93082638 |
| 50 | SIK2 | 0.92623804 |
| 51 | PKN1 | 0.92504820 |
| 52 | PDGFRA | 0.91624626 |
| 53 | MAPK12 | 0.89634640 |
| 54 | PINK1 | 0.89002761 |
| 55 | MET | 0.88913112 |
| 56 | MOS | 0.87106877 |
| 57 | CSNK1G2 | 0.84003194 |
| 58 | CAMKK2 | 0.83938827 |
| 59 | PNCK | 0.83203574 |
| 60 | CAMK2G | 0.83077700 |
| 61 | MAP3K12 | 0.82758319 |
| 62 | SGK2 | 0.82547796 |
| 63 | LMTK2 | 0.81887444 |
| 64 | CAMK1D | 0.77877295 |
| 65 | CAMK1 | 0.76599007 |
| 66 | AKT3 | 0.76343990 |
| 67 | STK11 | 0.76325678 |
| 68 | DAPK1 | 0.73798892 |
| 69 | STK39 | 0.72482648 |
| 70 | ERBB4 | 0.72027372 |
| 71 | ICK | 0.71497340 |
| 72 | ALK | 0.71241419 |
| 73 | PDK1 | 0.70544484 |
| 74 | OXSR1 | 0.68484175 |
| 75 | BRAF | 0.68180978 |
| 76 | PDPK1 | 0.66380038 |
| 77 | RIPK1 | 0.65119927 |
| 78 | SGK1 | 0.64724193 |
| 79 | GRK7 | 0.64419550 |
| 80 | DYRK1A | 0.63778640 |
| 81 | SGK3 | 0.61709842 |
| 82 | PRKCH | 0.60769170 |
| 83 | PHKG1 | 0.59862877 |
| 84 | PHKG2 | 0.59862877 |
| 85 | ROCK2 | 0.58984111 |
| 86 | TNIK | 0.58967280 |
| 87 | CAMK2D | 0.58248904 |
| 88 | FGFR3 | 0.57657279 |
| 89 | LATS1 | 0.55743873 |
| 90 | MAP3K1 | 0.51322199 |
| 91 | CDK18 | 0.50934418 |
| 92 | CAMK2B | 0.50335113 |
| 93 | BCR | 0.50264171 |
| 94 | PDK2 | 0.50258882 |
| 95 | CDK15 | 0.49856949 |
| 96 | MUSK | 0.49174365 |
| 97 | PRKCG | 0.48718158 |
| 98 | MAPK10 | 0.48441940 |
| 99 | MAP2K1 | 0.47313639 |
| 100 | CDK14 | 0.45870954 |
| 101 | PRKCZ | 0.45811884 |
| 102 | KDR | 0.45415052 |
| 103 | DAPK3 | 0.44925007 |
| 104 | PRKG1 | 0.43908221 |
| 105 | ERBB2 | 0.43258158 |
| 106 | PRKD1 | 0.42812505 |
| 107 | RPS6KA3 | 0.41988356 |
| 108 | ROCK1 | 0.41056121 |
| 109 | CASK | 0.39299681 |
| 110 | FGFR4 | 0.39288536 |
| 111 | MAPK7 | 0.39007895 |
| 112 | PAK3 | 0.38284340 |
| 113 | PRKAA1 | 0.37968039 |
| 114 | PTK2 | 0.37959462 |
| 115 | CDK11A | 0.37765139 |
| 116 | PRPF4B | 0.37584360 |
| 117 | PDGFRB | 0.37444601 |
| 118 | GRK1 | 0.37327298 |
| 119 | MAP3K7 | 0.36243873 |
| 120 | CAMK4 | 0.35723010 |
| 121 | CDK8 | 0.35109725 |
| 122 | FYN | 0.34680036 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 2.82548460 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.53082232 |
| 3 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.36052464 |
| 4 | Circadian entrainment_Homo sapiens_hsa04713 | 2.35110349 |
| 5 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.28368023 |
| 6 | GABAergic synapse_Homo sapiens_hsa04727 | 2.20459403 |
| 7 | Long-term potentiation_Homo sapiens_hsa04720 | 2.19422251 |
| 8 | Olfactory transduction_Homo sapiens_hsa04740 | 2.18160096 |
| 9 | Morphine addiction_Homo sapiens_hsa05032 | 2.12912429 |
| 10 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.02909812 |
| 11 | Salivary secretion_Homo sapiens_hsa04970 | 1.99404773 |
| 12 | Phototransduction_Homo sapiens_hsa04744 | 1.92216107 |
| 13 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.90147911 |
| 14 | Renin secretion_Homo sapiens_hsa04924 | 1.87555399 |
| 15 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.85529465 |
| 16 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.76916867 |
| 17 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.71598291 |
| 18 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.69805779 |
| 19 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.67151567 |
| 20 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.64863260 |
| 21 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.61327255 |
| 22 | Insulin secretion_Homo sapiens_hsa04911 | 1.61231180 |
| 23 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.58574692 |
| 24 | Long-term depression_Homo sapiens_hsa04730 | 1.53869169 |
| 25 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.51912613 |
| 26 | Histidine metabolism_Homo sapiens_hsa00340 | 1.47835151 |
| 27 | Cocaine addiction_Homo sapiens_hsa05030 | 1.43544496 |
| 28 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.39398447 |
| 29 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.37778266 |
| 30 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.36352188 |
| 31 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.33874883 |
| 32 | Gap junction_Homo sapiens_hsa04540 | 1.31751510 |
| 33 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.24432626 |
| 34 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.24394094 |
| 35 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.21078227 |
| 36 | Glioma_Homo sapiens_hsa05214 | 1.17229287 |
| 37 | Axon guidance_Homo sapiens_hsa04360 | 1.15529126 |
| 38 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.13689865 |
| 39 | Taste transduction_Homo sapiens_hsa04742 | 1.13616633 |
| 40 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.11790902 |
| 41 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.11768259 |
| 42 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.10809350 |
| 43 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.10234900 |
| 44 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.08118170 |
| 45 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.04143412 |
| 46 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.03714017 |
| 47 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.03087876 |
| 48 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.01456644 |
| 49 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.99997108 |
| 50 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.99596686 |
| 51 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.99315802 |
| 52 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.97929986 |
| 53 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.96828216 |
| 54 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.94427920 |
| 55 | Circadian rhythm_Homo sapiens_hsa04710 | 0.91622867 |
| 56 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.88364396 |
| 57 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.86540868 |
| 58 | Melanogenesis_Homo sapiens_hsa04916 | 0.84464024 |
| 59 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.84256505 |
| 60 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.83116745 |
| 61 | * Ras signaling pathway_Homo sapiens_hsa04014 | 0.82850621 |
| 62 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.81350631 |
| 63 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.79730740 |
| 64 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.79466517 |
| 65 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.78059834 |
| 66 | * Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.77909200 |
| 67 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.77710067 |
| 68 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.76615182 |
| 69 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.76230033 |
| 70 | ABC transporters_Homo sapiens_hsa02010 | 0.75439461 |
| 71 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.74173503 |
| 72 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.73742434 |
| 73 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.73495269 |
| 74 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.71624489 |
| 75 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.68611146 |
| 76 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.67983406 |
| 77 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.67006080 |
| 78 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.65224549 |
| 79 | Endocytosis_Homo sapiens_hsa04144 | 0.64564341 |
| 80 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.62333248 |
| 81 | Colorectal cancer_Homo sapiens_hsa05210 | 0.61554175 |
| 82 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.61279302 |
| 83 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.59753265 |
| 84 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.59276999 |
| 85 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.57634364 |
| 86 | Alcoholism_Homo sapiens_hsa05034 | 0.56963061 |
| 87 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.56696789 |
| 88 | Endometrial cancer_Homo sapiens_hsa05213 | 0.56298864 |
| 89 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.55045496 |
| 90 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.55004501 |
| 91 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.52961127 |
| 92 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.52645192 |
| 93 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.52159093 |
| 94 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.51636202 |
| 95 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.51596065 |
| 96 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.50939976 |
| 97 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.50850919 |
| 98 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.49580439 |
| 99 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.49185294 |
| 100 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.48063828 |
| 101 | Bile secretion_Homo sapiens_hsa04976 | 0.48007754 |
| 102 | Adherens junction_Homo sapiens_hsa04520 | 0.47770784 |
| 103 | Platelet activation_Homo sapiens_hsa04611 | 0.47710655 |
| 104 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.45626808 |
| 105 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.45071807 |
| 106 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.44199260 |
| 107 | Mineral absorption_Homo sapiens_hsa04978 | 0.42074335 |
| 108 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.41871585 |
| 109 | Tight junction_Homo sapiens_hsa04530 | 0.41672899 |
| 110 | Focal adhesion_Homo sapiens_hsa04510 | 0.41019358 |
| 111 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.39021846 |
| 112 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.38189375 |
| 113 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.36954817 |
| 114 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.36826903 |
| 115 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.36768835 |
| 116 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.36427963 |
| 117 | Prion diseases_Homo sapiens_hsa05020 | 0.36058680 |
| 118 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.35090670 |
| 119 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.34478655 |
| 120 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.33035281 |
| 121 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.32215635 |

